Skip to main
ALRN
ALRN logo

Aileron Therapeutics (ALRN) Market Capitalization Overview

Market Cap: $32.35M as of Jul 25, 2025

$32.35M
Past Month-$1.78M (5.19%)
As of Jul 25, 2025, Aileron Therapeutics (ALRN) has a market capitalization of $32.35M. Over the past 30 days, its market cap has decreased by -24.87%, while in the last 12 months, it has decreased by -35.09%.

Market capitalization represents the total value of Aileron Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Aileron Therapeutics (ALRN) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Aileron Therapeutics (ALRN) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Aileron Therapeutics (ALRN) Market Cap History

DateMarket CapChange
Jul 1, 2025$32.13M-24.87%
Jun 2, 2025$42.76M+18.55%
May 1, 2025$36.07M-4.87%
Apr 1, 2025$37.92M-7.89%
Mar 3, 2025$41.17M-1.04%
Feb 3, 2025$41.60M-14.67%
Jan 2, 2025$48.75M-21.05%

Aileron Therapeutics (ALRN) End of Year Market Cap History

DateMarket CapChange
2025$32.35M-35.09%
2024$49.84M+234.56%
2023$14.90M+38.39%
2022$10.77M-78.89%
2021$50.99M+11.91%
2020$45.56M

FAQs About Aileron Therapeutics (ALRN) Market Cap

As of Jul 25, 2025, the market capitalization of Aileron Therapeutics (ALRN) is $32.35M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Aileron Therapeutics’s market capitalization has decreased by -5.19%, changing from $34.12M to $32.35M as of Jul 25, 2025.

In the last 3 months, Aileron Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Aileron Therapeutics’s market capitalization increased from $14.90M in January to $49.84M in December, reflecting a 234.56% change.

In the past five years, Aileron Therapeutics (ALRN) has had a compound annual growth rate (CAGR) of 1.81% in market capitalization. This means its market cap has grown at an average rate of 1.81% per year.

Aileron Therapeutics (ALRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.